Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

BPH drug approved for use

  • Comment

The Scottish Medicines Consortium has approved Combodart (dutasteride 0.5mg/tamsulosin hydrochloride 0.4mg) for the treatment of benign prostatic hyperplasia (BPH) within NHS Scotland.

The drug is indicated for the treatment of moderate-to-severe BPH and reduction in the risk of acute urinary retention and BPH-related surgery.

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.